Akeso’s immunotherapy drug allowed half of its patients to go 11.1 months without their condition worsening.
About us, Contact us, Contribute, Privacy Policy, Review Guidelines, Legal Notice, 2023 MACH MEDIA
Home » Chinese drug maker Akeso hailed as biotechs DeepSeek moment amid US competition
Akeso’s immunotherapy drug allowed half of its patients to go 11.1 months without their condition worsening.